Flucytosine (5-FC)

DRUG2 trials

Sponsors

Anaeropharma Science, Inc., Transgene

Conditions

CancerColorectal NeoplasmsNeoplasmsTumors

Phase 1

Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors

SuspendedNCT01562626

Anaeropharma Science, Inc.Cancer, Neoplasms, Tumors

Start: 2012-09-30End: 2021-05-31Target: 75Updated: 2021-05-12

Study of Intrahepatic Arterial Infusion of TG6002 in Combination With 5-FC in Patients With Metastatic Colorectal Cancer

TerminatedNCT04194034

TransgeneColorectal Neoplasms

Start: 2020-01-17End: 2023-02-23Updated: 2023-06-23